MannKind Announces FDA Approval of Furoscix ReadyFlow™, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic Kidney Disease
Globe Newswire•24/07/2026•06:30 ET
0
Whiz Insights
Get started
Create a free account to read the full story.